This year’s iconic CHRISTMAS LECTURES at the Royal Institution are focusing on ‘Life Fantastic’, and the breath-taking science associated with developmental biology. Dr Alison Woollard, lecturer in genetics at the University of Oxford, will describe a range of organisms, from worms and lobsters to dogs, to help us understand some of life’s most fascinating questions. Describing a cell as “the building block for an entire organism”, she’s really excited by what this means for diagnosis, treatment and prevention of disease.
The Cell and Gene Therapy Catapult helps to move cell and gene therapies from the lab bench to the patient’s bedside, as our Chief Clinical Officer Dr Natalie Mount explains. Good science underpins it all, which is why we’re delighted to support the CHRISTMAS LECTURES.
We’re not the only ones to recognise the potential of cells to treat or cure many diseases – the exciting area of cell and gene therapy. There’s fantastic early stage cell and gene therapy research ongoing in many charities, universities and companies in the UK and across the world. It’s our role at the Cell and Gene Therapy Catapult to work with this community to develop its research into new medicines. We’re pleased to play our part in this ‘bench to bedside’ journey – helping to turn great science into great medicine.
There are several things that the Cell and Gene Therapy Catapult focuses on as it plays its part in the bench to bedside chain. Using the cell and gene therapy knowledge from our team and our collaborators, we are helping progress ground-breaking new treatments to the later stages of development. This makes them ideal for further funding by investors and companies, who can take them through to approval so that they get to the people who need them – the patients.